Putative virulence factors of Aspergillus fumigatus

Clinical and Experimental Allergy

Volumn 30, Issue 4, 2000, Pages 476-484

  Tomee, J F Ch ^a   Kauffman, H F ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Airway epithelium; Aspergillus fumigatus elastase; Cellular defence; Fungal toxins; Mucosal defence; Proteolytic enzymes; Virulence factors

Indexed keywords

ALKALINE PROTEINASE; COMPLEMENT INHIBITOR; MYCOTOXIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CILIATED EPITHELIUM; COMPLEMENT INHIBITION; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OPSONIZATION; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY EPITHELIUM; REVIEW;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FUNGAL PROTEINS; HUMANS; MYCOTOXINS; VIRULENCE;

EID: 0034056686     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00796.x     Document Type: Review

References (72)

1. 1 Frey CL, Drutz DJ. Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis 1986; 153:933-43.
2. 2 Hensel M, Arst HNJ, Aufauvre-Brown A, Holden DW. The role of the Aspergillus fumigatus areA gene in invasive pulmonary aspergillosis. Mol Gen Genet 1998; 258:553-7.
3. 3 Mullins J, Seaton A. Fungal spores in lung and sputum. Clin Allergy 1978; 8:525-33.
4. 4 Aufauvre-Brown A, Brown JS, Holden DW. Comparison of virulence between clinical and environmental isolates of Aspergillus fumigatus. Eur J Clin Microbiol Infect Dis 1998; 17:778-80.
5. 5 Amitani R, Sato A, Matsui Y et al. Effects of Aspergillus species culture filtrates on human respiratory ciliated epithelium in vitro [abstract]. Am Rev Respir Dis 1992; 145:A548.
6. 6 Amitani R, Taylor G, Elezis EN et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63:3266-71.
7. 7 Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982; 69:617-31.
8. 8 Diamond RD, Huber E, Haudenschild CC. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. J Infect Dis 1983; 147:474-83.
9. 9 Cusumano V, Costa GB, Seminara S. Effect of aflatoxins on rat peritoneal macrophages. Appl Environ Microbiol 1990; 11:3482-4.
10. 10 Müllbacher A, Waring P, Eichner RD. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol 1985; 131:1251-8.
11. 11 Ikegami Y, Amitani R, Murayama T et al. Effects of alkaline protease or restrictocin deficient mutants of Aspergillus fumigatus on human polymorphonuclear leukocytes. Eur Respir J 1998; 12:607-11.
12. 12 Robertson MD, Seaton A, Raeburn JA, Milne LJ. Inhibition of phagocyte migration and spreading by spore diffusates of Aspergillus fumigatus. J Med Vet Mycol 1987; 25:389-96.
13. 13 Robertson MD, Seaton A, Milne LJ, Raeburn JA. Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax 1987; 42:466-72.
14. 14 Robertson MD, Seaton A, Milne LJ, Raeburn JA. Suppression of host defences by Aspergillus fumigatus. Thorax 1987; 42:19-25.
15. 15 Nicholson WJ, Slight J, Donaldson K. Inhibition of the transcription factors NF-kappaB and AP-1 underlies loss of cytokine gene expression in rat alveolar macrophages treated with a diffusible product from the spores of Aspergillus fumigatus. Am J Respir Cell Mol Biol 1996; 15:88-96.
16. 16 Hamilton AJ, Holdom MD, Jeavons L. Expression of the Cu,Zn superoxide dismutase of Aspergillus fumigatus as determined by immunochemistry and immunoelectron microscopy. FEMS Immunol Med Microbiol 1996; 14:95-102.
17. 17 Levitz SM, Diamond RD. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J Infect Dis 1985; 152:33-42.
18. 18 Henwick S, Hetherington SV, Patrick CC. Complement binding to Aspergillus conidia correlates with pathogenicity. J Lab Clin Med 1993; 122:27-35.
19. 19 Washburn RG, Hammer CH, Bennett JE. Inhibition of complement by culture supernatants of Aspergillus fumigatus. J Infect Dis 1986; 154:944-51.
20. 20 Washburn RG, DeHart DJ, Agwu DE, Bryant-Varela BJ, Julian NC. Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. Infect Immun 1990; 58:3508-15.
21. 21 Sturtevant JE, Latgé J-P. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 1992; 60:1913-18.
22. 22 Tsai HF, Washburn RG, Chang YC, Kwon-Chung KJ. Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition. Mol Microbiol 1997; 26:175-83.
23. 23 DeHart DJ, Agwu DE, Julian NC, Washburn RG. Binding and germination of Aspergillus fumigatus conidia on cultured A549 pneumocytes. J Infect Dis 1997; 175:146-50.
24. 24 Bromley IMJ, Donaldson K. Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax 1996; 51:1203-9.
25. 25 Tronchin G, Esnault K, Renier G, Filmon R, Chabasse D, Bouchara JP. Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia. Infect Immun 1997; 65:9-15.
26. 26 Tronchin G, Bouchara J-P, Larcher G, Lissitzky J-C, Chabasse D. Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation. Biol Cell 1993; 77:201-8.
27. 27 Gil ML, Pe-alver MC, Lopez-Ribot JL, O'Connor JE, Martinez JP. Binding of extracellular matrix proteins to Aspergillus fumigatus conidia. Infect Immun 1996; 64:5239-47.
28. 28 Pe-alver MC, O'Connor JE, Martínez JP, Gil ML. Binding of human fibronectin to Aspergillus fumigatus conidia. Infect Immun 1996; 64:1146-53.
29. 29 Bouchara J-P, Bouali A, Tronchin G, Robert R, Chabasse D, Senet JM. Binding of fibrinogen to the pathogenic Aspergillus species. J Med Vet Mycol 1988; 26:327-34.
30. 30 Coulot P, Bouchara J-P, Renier G et al. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun 1994; 62:2169-77.
31. 31 Annaix V, Bouchara J-P, Larcher G, Chabasse D, Tronchin G. Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia. Infect Immun 1992; 60:1747-55.
32. 32 Jensen TD, Schonheyder HC, Andersen P, Stenderup A. Binding of C-reactive protein to Aspergillus fumigatus fractions. J Med Microbiol 1986; 21:173-7.
33. 33 Latgé J-P, Paris S, Sarfati J et al. The genus Aspergillus: from taxonomy and genetics to industrial application. In: Powell KA, Reswick A, Peberdy JF, eds. Exoantigens of Aspergillus fumigatus: serodiagnosis and virulence. New York, London: Plenum Press, 1994:321-39.
34. 34 Tilden EB, Hatten EH, Freeman S, Williamson WM, Koenig VL. Preparation and properties of the endotoxins of Aspergillus fumigatus and A. flavus. Mycopathologia 1961; 14:325-46.
35. 35 Longbottom JL, Pepys J. Pulmonary aspergillosis: diagnostic and immunological significance of antigens and C-reactive substance in Aspergillus fumigatus. J Pathol Bacteriol 1964; 88:141-51.
36. 36 Yamazaki M, Suzuki S, Miyaki K. Tremorgenic toxins from Aspergillus fumigatus. Fres Chem Pharm Bull 1971; 19:1739-40.
37. 37 Bardana Jr EJ. The clinical spectrum of aspergillosis. Part 1: Epidemiology, pathogenicity, infection in animals, and immunology of Aspergillus. Crit Rev Clin Lab Sci 1980; 13:21-83.
38. 38 Cui CB, Kakeya H, Osada H. Spirotryprostatin B, a novel mammalian cell cycle inhibitor produced by Aspergillus fumigatus. J Antibiot (Tokyo) 1996; 49:832-5.
39. 39 Müllbacher A, Eichner RD. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci USA 1984; 81:3835-7.
40. 40 Eichner RD, Al Salami M, Wood PR, Müllbacher A. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol 1986; 8:789-97.
41. 41 Eichner RD, Waring P, Geue AM, Braithwaite AW, Mullbacher A. Gliotoxin causes oxidative damage to plasmid and cellular DNA [published erratum appeared in J Biol Chem May 25; 263(15): 7438]. J Biol Chem 1988; 263: 3772-7.
42. 42 Pahl HL, Krausz B, Schulze-Osthoff K et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kB. J Exp Med 1996; 183:1829-40.
43. 43 Arruda LK, Platts-Mills TA, Fox JW, Chapman MD. Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med 1990; 172:1529-32.
44. 44 Nishimura K. Experimental studies on the invasion of the central nervous system in mice by Aspergillus fumigatus. Jpn J Med Mycol 1969; 10:170-7.
45. 45 Miyaji M, Nishimura K. Aspergillus fumigatus and the fungus invasiveness of mouse brain. Mycopathologia 1977; 62:161-6.
46. 46 Staib F. Pleural fluid as nutrient substratum for Aspergillus fumigatus and A. flavus. Submerged growth in pleural fluid and extracellular proteolysis in pleural fluid agar. A preliminary report. Zentralbl Bakteriol Mikrobiol Hyg A 1985; 260:543-9.
47. 47 Jönsson AG, Martin SM. Protease production by Aspergillus fumigatus. Agric Biol Chem 1964; 28:734-9.
48. 48 Kothary MH, Chase TJ, Macmillan JD. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun 1984; 43:320-5.
49. 49 Rhodes JC, Bode RB, McCuan-Kirsch CM. Elastase production in clinical isolates of Aspergillus. Diagn Microbiol Infect Dis 1988; 10:165-70.
50. 50 Rhodes JC. Aspergillus proteinases and their interactions with host tissues. Can J Bot 1995; 73(Suppl. 1E-H): S1126-31.
51. 51 Bouchara J-P, Larcher G, Annaix V, Bucher P, Tronchin G, Chabasse D. Fibrinogenolytic activity of Aspergillus fumigatus culture filtrate. J Mycol Med 1991; 1:105-11.
52. 52 Larcher G, Bouchara JP, Annaix V, Symoens F, Chabasse D, Tronchin G. Purification and characterization of a fibrinogenolytic serine proteinase from Aspergillus fumigatus culture filtrate. FEBS Lett 1992; 308:65-9.
53. 53 Moutaouakil M, Monod M, Prévost M-C, Bouchara J-P, Paris S, Latgé J-P. Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. J Med Microbiol 1993; 39:393-9.
54. 54 Reichard U, Buttner S, Eiffert H, Staib F, Rüchel R. Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 1990; 33:243-51.
55. 55 Smith JM, Tang CM, van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restrictocin and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247-54.
56. 56 Kolattukudy PE, Lee JD, Rogers LM et al. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun 1993; 61:2357-68.
57. 57 Frosco M, Fahed C, Chase Jr T, Macmillan JD. Inhibition of Aspergillus fumigatus elastase with monoclonal antibodies produced by using denaturated elastase as an immunogen. Infect Immun 1992; 60:735-41.
58. 58 Frosco M-B, Chase Jr T, Macmillan JD. The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice. Mycopathologia 1994; 125:65-76.
59. 59 Tomee JFC, Kauffman HF, Klimp AH, de Monchy JGR, Koëter GH, Dubois AEJ. Immunologic significance of a collagen-derived culture filtrate containing proteolytic activity in Aspergillus-related diseases. J Allergy Clin Immunol 1994; 93:768-78.
60. 60 Moser M, Menz G, Blaser K, Crameri R. Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus. Infect Immun 1994; 62:936-42.
61. 61 Tomee JFC, van der Werf TS, Latgé J-P, Koëter GH, Dubois AEJ, Kauffman HF. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 1995; 151:199-204.
62. 62 Tang CM, Cohen J, Krausz T, van Noorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun 1993; 61:1650-6.
63. 63 Smith JM, Davies JE, Holden DW. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin. Mol Microbiol 1993; 9:1071-7.
64. 64 Jaton Ogay K, Paris S, Huerre M et al. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol 1994; 14:917-28.
65. 65 Monod M, Paris S, Sarfati J, Jaton-Ogay K, Ave P, Latgé J-P. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett 1993; 80:39-46.
66. 66 Reichard U. The significance of secretory and structure-associated proteases of Aspergillus fumigatus for the pathogenesis of invasive aspergillosis. Mycoses 1998; 41(Suppl. 1):78-82.
67. 67 Robinson BW, Venaille TJ, Mendis AH, McAleer R. Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol 1990; 86:726-31.
68. 68 Tran Van Ky P, Uriel J, Rose F. Caractérisation de types d'activités enzymatiques dans des extraits antigéniques d'Aspergillus fumigatus après électrophorèse et immunoélectrophorèse en agarose. Ann l'Institut Pasteur 1966; 111:161-70.
69. 69 Beauvais A, Monod M, Debeaupuis JP, Diaquin M, Kobayashi H, Latgé J-P. Biochemical and antigenic characterization of a new dipeptidyl-peptidase isolated from Aspergillus fumigatus. J Biol Chem 1997; 272:6238-44.
70. 70 Tomee JFC, Wierenga ATJ, Hiemstra PS, Kauffman HF. Proteases from Aspergillus induce release of pro-inflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997; 176:300-3.
71. 71 Kauffman HF, Tomee JFC. Inflammatory cells and airway defence against Aspergillus fumigatus. Immunol Allergy Clin North Am 1998; 18:619-40.
72. 72 Mondon P, De Champs C, Donadille A, Ambroise Thomas P, Grillot R. Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis. J Med Microbiol 1996; 45:186-91.